Treatment-related mutagenic processes in acute lymphoblastic leukemia. [PDF]
Van der Ham CG +2 more
europepmc +1 more source
Incidence of Thiopurine-Induced Severe Myelosuppression in a Nationwide Cohort of Patients With Inflammatory Bowel Disease. [PDF]
Khan N, Patel D, Sundararajan R.
europepmc +1 more source
[Pharmacogenetic study of thiopurine S-methyltransferase (TPMT) and thiopurine toxicity].
H, Corominas +3 more
openaire +1 more source
DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemia. [PDF]
Koch MR +17 more
europepmc +1 more source
From niche to blockbuster: a greater role for allopurinol in maintenance treatment of acute lymphoblastic leukemia. [PDF]
Stanulla M.
europepmc +1 more source
Inhibition of <i>Clostridioides difficile</i>-Specific DNA Adenine Methyltransferase CamA by Analogs of <i>S</i>‑Adenosyl‑l‑methionine. [PDF]
Zhou J +8 more
europepmc +1 more source
Dramatic Changes in Thiopurine Metabolite Levels in a Patient With Inflammatory Bowel Disease Treated With Tirzepatide for Weight Loss. [PDF]
Klein JA +4 more
europepmc +1 more source
Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.
Nguyen CM, Mendes MA, Ma JD.
europepmc +1 more source
Gene polymorphisms associated with immunosuppressant adverse effects in systemic lupus erythematosus: a narrative review. [PDF]
Hamdani S +3 more
europepmc +1 more source

